Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

The conclusion of the Expert Council reports an agreement on the place of the P2Y₁₂ receptor blocker prasugrel in the early invasive treatment of patients with acute coronary syndrome ACS, according to the results of the multicenter randomized controlled study ISAR-REACT 5. Prasugrel should be considered the preferred P2Y₁₂ receptor blocker in the planned primary percutaneous coronary intervention and early invasive management of patients with ST segment elevation ACS. Herewith, prasugrel intake in patients with non-ST segment elevation ACS is preferable after coronary angiography and decision for coronary stenting.

1. Schüpke S, Neumann F-J, Menichelli M, et al. Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med. 2019;381:1524-34. doi:10.1056/NEJMoa1908973.

2. Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267-315. doi:10.1093/eurheartj/ehv320.

3. Amsterdam EA, Wenger N, Brindis RG, et al. 2014 AHA/ACC guidelines for the management of patients with non–ST-elevation acute coronary syndrome: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e344-e426. doi:10.1016/j.jacc.2014.09.017.

4. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-77. doi:10.1093/eurheartj/ehx393.

5. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JACC. 2013;61(4):e78-e140. doi:10.1016/j.jacc.2012.11.019.

6. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133:1135-47. doi:10.1161/CIR.0000000000000336.

7. Valgimigli M, Bueno H, Byrne RA, et al. ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213-60. doi:10.1093/eurheartj/ehx419.

8. Ruda MYa, Averkov OV, Golitsyn SP, et al. Diagnosis and treatment of patients with acute myocardial infarction with St segment elevation electrocardiogram. Clinical recommendations. Recommendations Of the society of specialists in emergency cardiology. Cardiology Bulletin. 2014;4:3-60. (In Russ.)

9. Ruda MYa, Averkov OV, Panchenko EP, Yavelov IS. Recommendations Of the society of specialists in emergency cardiology. Diagnosis and treatment of acute coronary syndrome without persistent ST segment elevation electrocardiogram. Part 1. Kardiologiia. 2017;57(8):80-100. (In Russ.) doi:10.18087/cardio.2017.8.10023

10. Ruda MYa, Averkov OV, Panchenko EP, Yavelov IS. Recommendations Of the society of specialists in emergency cardiology. Diagnosis and treatment of acute coronary syndrome without persistent ST segment elevation electrocardiogram. Part 2. Kardiologiia. 2017;57(9):83-96. (In Russ.) doi:10.18087/cardio.2017.9.10026.

11. Ruda MYa, Averkov OV, Panchenko EP, Yavelov IS. Recommendations Of the society of specialists in emergency cardiology. Diagnosis and treatment of acute coronary syndrome without persistent ST segment elevation electrocardiogram. Part 3. Kardiologiia. 2017;57(10):98-104. (In Russ.) doi:10.18087/cardio.2017.10.10047.

12. Ruda MYa, Averkov OV, Panchenko EP, Yavelov IS. Recommendations Of the society of specialists in emergency cardiology. Diagnosis and treatment of acute coronary syndrome without persistent ST segment elevation electrocardiogram. Part 4. Kardiologiia. 2017;57(11):94-104. (In Russ.) doi:10.18087/cardio.2017.11.10059.

13. Wiviott SD, Antman EM, Gibson CM, et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel — Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). Am Heart J. 2006;152:627-35.

14. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes N Engl J Med 2007;357:2001-15.

15. Wallentin L, Backer RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-57. doi:10.1056/NEJMoa0904327.

16. Olier I, Sirker A, Hildick-Smith DJR, et al., on behalf of the British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research. Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention. Heart. 2018;104(20):1683-90. doi:10.1136/heartjnl-2017-312366.

17. Watti H, Dahal K, Zabher H, et al. Comparison of prasugrel and ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A metaanalysis of randomized and non-randomized studies. International Journal of Cardiology. 2017;249:66-72. doi:10.1016/j.ijcard.2017.07.103.

18. Motovska Z, Hlinomaz O, Kala P, et al. 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor. J Am Coll Cardiol. 2018 Jan 30;71(4):371-81. doi:10.1016/j.jacc.2017.11.008.